The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
The current vaccine against tuberculosis, live attenuated Mycobacterium bovis BCG, has variable efficacy, but development of an effective alternative is severely hampered by the lack of an immune correlate of protection. There has been a recent resurgence of interest in functional in vitro mycobacterial growth inhibition assays (MGIAs), which provide a measure of a range of different immune mechanisms and their interactions. We identified a positive correlation between mean corpuscular haemoglobin and in vitro growth of BCG in whole blood from healthy UK human volunteers. Mycobacterial growth in peripheral blood mononuclear cells (PBMC) from both humans and macaques was increased following the experimental addition of haemoglobin (Hb) or ferric iron, and reduced following addition of the iron chelator deferoxamine (DFO). Expression of Hb genes correlated positively with mycobacterial growth in whole blood from UK/Asian adults and, to a lesser extent, in PBMC from South African infants. Taken together our data indicate an association between Hb/iron levels and BCG growth in vitro, which may in part explain differences in findings between whole blood and PBMC MGIAs and should be considered when using such assays.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
Scientific reports - 7(2017) vom: 03. März, Seite 43478 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tanner, Rachel [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
BCG Vaccine |
|---|
| Anmerkungen: |
Date Completed 13.11.2018 Date Revised 24.03.2024 published: Electronic ErratumIn: Sci Rep. 2019 Apr 3;9(1):5596. - PMID 30944352 Citation Status MEDLINE |
|---|
| doi: |
10.1038/srep43478 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM269480137 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM269480137 | ||
| 003 | DE-627 | ||
| 005 | 20240324233915.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/srep43478 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1344.xml |
| 035 | |a (DE-627)NLM269480137 | ||
| 035 | |a (NLM)28256545 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tanner, Rachel |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.11.2018 | ||
| 500 | |a Date Revised 24.03.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a ErratumIn: Sci Rep. 2019 Apr 3;9(1):5596. - PMID 30944352 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The current vaccine against tuberculosis, live attenuated Mycobacterium bovis BCG, has variable efficacy, but development of an effective alternative is severely hampered by the lack of an immune correlate of protection. There has been a recent resurgence of interest in functional in vitro mycobacterial growth inhibition assays (MGIAs), which provide a measure of a range of different immune mechanisms and their interactions. We identified a positive correlation between mean corpuscular haemoglobin and in vitro growth of BCG in whole blood from healthy UK human volunteers. Mycobacterial growth in peripheral blood mononuclear cells (PBMC) from both humans and macaques was increased following the experimental addition of haemoglobin (Hb) or ferric iron, and reduced following addition of the iron chelator deferoxamine (DFO). Expression of Hb genes correlated positively with mycobacterial growth in whole blood from UK/Asian adults and, to a lesser extent, in PBMC from South African infants. Taken together our data indicate an association between Hb/iron levels and BCG growth in vitro, which may in part explain differences in findings between whole blood and PBMC MGIAs and should be considered when using such assays | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a BCG Vaccine |2 NLM | |
| 650 | 7 | |a Hemoglobins |2 NLM | |
| 650 | 7 | |a Iron Chelating Agents |2 NLM | |
| 650 | 7 | |a Iron |2 NLM | |
| 650 | 7 | |a E1UOL152H7 |2 NLM | |
| 650 | 7 | |a Deferoxamine |2 NLM | |
| 650 | 7 | |a J06Y7MXW4D |2 NLM | |
| 700 | 1 | |a O'Shea, Matthew K |e verfasserin |4 aut | |
| 700 | 1 | |a White, Andrew D |e verfasserin |4 aut | |
| 700 | 1 | |a Müller, Julius |e verfasserin |4 aut | |
| 700 | 1 | |a Harrington-Kandt, Rachel |e verfasserin |4 aut | |
| 700 | 1 | |a Matsumiya, Magali |e verfasserin |4 aut | |
| 700 | 1 | |a Dennis, Mike J |e verfasserin |4 aut | |
| 700 | 1 | |a Parizotto, Eneida A |e verfasserin |4 aut | |
| 700 | 1 | |a Harris, Stephanie |e verfasserin |4 aut | |
| 700 | 1 | |a Stylianou, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Naranbhai, Vivek |e verfasserin |4 aut | |
| 700 | 1 | |a Bettencourt, Paulo |e verfasserin |4 aut | |
| 700 | 1 | |a Drakesmith, Hal |e verfasserin |4 aut | |
| 700 | 1 | |a Sharpe, Sally |e verfasserin |4 aut | |
| 700 | 1 | |a Fletcher, Helen A |e verfasserin |4 aut | |
| 700 | 1 | |a McShane, Helen |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Scientific reports |d 2011 |g 7(2017) vom: 03. März, Seite 43478 |w (DE-627)NLM215703936 |x 2045-2322 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2017 |g day:03 |g month:03 |g pages:43478 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/srep43478 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2017 |b 03 |c 03 |h 43478 | ||